We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New LED Microscope Completes Line of Clinical and Research Tools

By LabMedica International staff writers
Posted on 26 Jul 2015
A popular microscope used for both clinical and research applications is now available with LED illumination.

The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools for demanding tasks in life science routine and research applications. More...
With their powerful transmitted light illumination, high-quality optical performance, and state-of-the-art accessories, the Leica DM2500 and DM2500 LED are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.

The difference between the two microscopes is their illumination: The Leica DM2500 LED is equipped with LED illumination for transmitted light, whereas the Leica DM2500 works with halogen. Both types of illumination render a realistic impression of the colors of the sample, so that users in clinical applications, such as the frequently used HE specimen staining, are able to assess the colors of their samples accurately. With the launch of the Leica DM2500 LED, Leica Microsystems has completed its Leica DM1000 to 3000 series of microscopes. All the models in this series are now available with LED illumination. The microscopes are certified for in vitro diagnostics (IVD) use.

The ultra-bright LED illumination of the newly released Leica DM2500 LED offers a constant color temperature at all light intensities, enabling particularly fine differentiation of colors in stained specimens. Users benefit from the brightness and color accuracy of the LED illumination in all other transmitted light contrasting techniques, such as brightfield, polarized light, and darkfield. LEDs offer the general advantages of no sample heating, low energy consumption, and long life time.

"The specially-developed LED illumination makes the Leica DM2500 LED an ideal microscope for challenging experiments requiring different contrasting techniques and for users who prefer a manual instrument," said Dr. Jasna Gilbert, product manager at Leica Microsystems. "The Leica DM2500 LED has now completed our DM1000 to 3000 series. All the models are available with either LED or halogen illumination. Besides the new illumination, the Leica DM2500 LED offers all the other benefits of the microscope series such as the unique ergonomics design for user comfort and convenience."

Related Links:

Leica



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Uric Acid Meter
PA-16
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.